TWIST BIOSCIENCE CORP
NASDAQ: TWST (Twist Bioscience Corporation)
Kemas kini terakhir: 9 jam lalu41.07
-0.51 (-1.23%)
| Penutupan Terdahulu | 41.58 |
| Buka | 41.29 |
| Jumlah Dagangan | 1,539,364 |
| Purata Dagangan (3B) | 1,438,626 |
| Modal Pasaran | 2,516,508,928 |
| Harga / Jualan (P/S) | 6.60 |
| Harga / Buku (P/B) | 5.39 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 2 Feb 2026 |
| Margin Keuntungan | -54.98% |
| Margin Operasi (TTM) | -44.79% |
| EPS Cair (TTM) | -3.25 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 23.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 18.25% |
| Nisbah Semasa (MRQ) | 4.51 |
| Aliran Tunai Operasi (OCF TTM) | -56.11 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -16.89 M |
| Pulangan Atas Aset (ROA TTM) | -15.04% |
| Pulangan Atas Ekuiti (ROE TTM) | -38.22% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Menaik | Menaik |
| Diagnostics & Research (Global) | Menaik | Menaik | |
| Stok | Twist Bioscience Corporation | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.40 |
|
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.98% |
| % Dimiliki oleh Institusi | 115.15% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| William Blair Investment Management, Llc | 30 Sep 2025 | 4,142,283 |
| Soleus Capital Management, L.P. | 30 Sep 2025 | 1,866,234 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 79.00 (Guggenheim, 92.36%) | Beli |
| Median | 42.00 (2.26%) | |
| Rendah | 39.00 (Barclays, -5.04%) | Beli |
| Purata | 50.50 (22.96%) | |
| Jumlah | 4 Beli | |
| Harga Purata @ Panggilan | 34.58 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Guggenheim | 26 Jan 2026 | 79.00 (92.35%) | Beli | 42.46 |
| TD Cowen | 08 Jan 2026 | 43.00 (4.70%) | Beli | 34.74 |
| Barclays | 15 Dec 2025 | 39.00 (-5.04%) | Beli | 31.07 |
| 17 Nov 2025 | 37.00 (-9.91%) | Beli | 26.46 | |
| Stephens & Co. | 04 Nov 2025 | 41.00 (-0.17%) | Beli | 30.06 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| FINN PATRICK JOHN | - | 42.94 | -2,390 | -102,627 |
| Jumlah Keseluruhan Kuantiti Bersih | -2,390 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -102,627 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 42.94 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| FINN PATRICK JOHN | Pegawai | 23 Jan 2026 | Jual (-) | 2,390 | 42.94 | 102,627 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Jan 2026 | Pengumuman | Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue |
| 18 Dec 2025 | Pengumuman | Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference |
| 04 Dec 2025 | Pengumuman | Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research |
| 14 Nov 2025 | Pengumuman | Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results |
| 04 Nov 2025 | Pengumuman | Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference |
| 03 Nov 2025 | Pengumuman | Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |